Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
University of Oxford
Biotech
Amgen weaves in UK biotech with up to $840M acquisition
Amgen has stitched together a deal worth up to $840 million for Dark Blue Therapeutics, a private biotech in Oxford.
Gabrielle Masson
Jan 6, 2026 10:35am
GSK and Oxford University ink cancer vaccine research pact
Jan 26, 2025 7:01pm
Bipolar research initiative announces $36M in new funding
Sep 30, 2024 1:13pm
Barinthus' gets $35M booster from CEPI to develop MERS shot
Dec 21, 2023 10:10am
Team behind AstraZeneca's COVID shot reunites on pandemic prep
Aug 30, 2023 10:40am
Oxford malaria vaccine maintains high efficacy with booster
Sep 8, 2022 11:00am
